Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Wide Variety of Gels Can Now Be Analyzed With One Imaging System

By BiotechDaily International staff writers
Posted on 27 Mar 2013
Image: GelDoc-Ite, the new imaging system for gel documentation from UVP (Photo courtesy of UVP, LLC).
Image: GelDoc-Ite, the new imaging system for gel documentation from UVP (Photo courtesy of UVP, LLC).
A new high-quality gel imager provides flexible, simple, efficient, and economical imaging, analysis, and documentation within a single system.

UVP, LLC (UVP; Upland, CA, USA) introduces its new “GelDoc-Ite Imager” designed for fast, simple imaging of various gel types. This imager "provides researchers with a resourceful and economical system [while] hardware features facilitate ease of use [...]. Side access doors are conveniently located for cutting or moving gels, a UV-safe gel viewer window enables viewing of illuminated gels, and a camera and zoom lens configuration captures large gels or zooms in on details," said UVP management team member Mike Capps.

The integrated UV transilluminator accommodates a wide range of gel sizes and samples are illuminated with a choice of transilluminator for maximizing fluorophore stain excitation. A unit with midrange 302 nm UV is for viewing ethidium bromide (EtBr) and other stains, while the 3UV model provides user-selectable 302, 365, and 254 nm excitation. An EtBr emission filter is included as standard with the GelDoc-Ite, while a variety of optional emission filters are available to suit various applications. The modular design enables placement of converter plates onto the UV transillumination surface, converting midrange UV to specific wavelengths for illumination of a variety of stains. The “Visi-Blue” Converter Plate converts the UV to 460–470 nm blue light for viewing stains such as SYBR Green, SYBR Safe, and GelGreen. When white light transillumination is required, the White Light Converter Plate can be used for viewing gels such as Coomassie Blue and Silver stain.

GelDoc-Ite simplifies imaging with the intuitive, workflow-based “VisionWorks LS” software. Easy-to-use one-touch buttons enable fast image acquisition, while the software controls the scientific grade CCD camera, which captures high quality, publication-ready images. Researchers can conduct 1D analysis and generate extensive quantitative data using molecular weight, histograms, lane profile graphs and other tools. Once analysis is complete, exporting result data to Excel and other programs for documentation and publication is accomplished with the software's integrated export tools.

With its compact size, the GelDoc-Ite Imager greatly reduces lab bench-space requirements and, with its user-friendly system, minimal operator training is required. Its design enables researchers to easily view gels using multiple light sources, to quickly capture and save publication-quality images, and to analyze lanes and bands. Fluorescent, colorimetric, or blue light imaging of a wide variety of gels can now be satisfied within this single system.

Related Links:

UVP, LLC
GelDoc-Ite



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.